The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents

Summary

The primary objective of this study is to compare the efficacy of Bonjesta for the treatment of nausea and vomiting of pregnancy (NVP) in pregnant adolescents aged 12 to 17 years with placebo. The secondary objective of this study is to compare the safety of Bonjesta in pregnant adolescents aged 12 to 17 years with placebo.

Timeline

Start

2022-05-01

Primary completion

2027-12

Completion

2027-12

Outcome

Outcome not reported

Stopped: “The study has been suspended due to the number of patients being so small, rendering the study unfeasible within a reasonable period of time.”

Drugs

Indications

No indication recorded.